- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 407/00 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group
Patent holdings for IPC class C07D 407/00
Total number of patents in this class: 62
10-year publication summary
|
2
|
2
|
0
|
1
|
0
|
5
|
0
|
0
|
0
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Tapestry Pharmaceuticals, Inc. | 22 |
3 |
| Industrial Technology Research Institute | 5201 |
2 |
| Wisconsin Alumni Research Foundation | 3903 |
2 |
| AB Pharma Ltd. | 14 |
2 |
| Korea Research Institute of Chemical Technology | 1497 |
2 |
| Kosan Biosciences, Inc. | 17 |
2 |
| Reliance Industries Limited | 464 |
2 |
| Samyang Holdings Corporation | 215 |
2 |
| Shanghai Ennovabio Pharmaceuticals Co., Ltd. | 34 |
2 |
| Hanjin-chemical Co.,Ltd. | 2 |
2 |
| LG Chem, Ltd. | 18010 |
1 |
| Pfizer Inc. | 3435 |
1 |
| Centre National de La Recherche Scientifique | 11171 |
1 |
| Bayer Intellectual Property GmbH | 2336 |
1 |
| Massachusetts Institute of Technology | 10339 |
1 |
| Sumitomo Chemical Company, Limited | 9002 |
1 |
| Battelle Memorial Institute | 2631 |
1 |
| Accord Healthcare Ltd. | 1 |
1 |
| Alios BioPharma, Inc. | 60 |
1 |
| Aventis Pharma S.A. | 37 |
1 |
| Other owners | 31 |